Tumor cell uptake of CD38-targeted nanoparticles increased over nontargeted nanoparticles, with increasing uptake of nanoparticles formulated with 0.1–0.5% peptide density, with a large drop occurring between 0.5 and 1% peptide density. Here, CD38 is linked to neoplasm.